Plasma-Powered gel could revolutionize chronic wound healing
NCT ID NCT07541196
First seen Apr 23, 2026 · Last updated May 28, 2026 · Updated 8 times
Summary
This study tests a special hydrogel made with plasma-activated water to see if it helps heal chronic wounds like diabetic foot ulcers and pressure sores faster than standard treatments. About 50 adults with wounds that haven't healed for over 3 months will either get the new gel or usual care for 12 weeks. Researchers will measure wound size, infection levels, and pain to check if the gel is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VENOUS LEG ULCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Plasma Physics Laboratory, National Institute of Nuclear Research
RECRUITINGOcoyoacac, State of Mexico, 52750, Mexico
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.